[go: up one dir, main page]

IL159494A0 - 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity - Google Patents

6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity

Info

Publication number
IL159494A0
IL159494A0 IL15949402A IL15949402A IL159494A0 IL 159494 A0 IL159494 A0 IL 159494A0 IL 15949402 A IL15949402 A IL 15949402A IL 15949402 A IL15949402 A IL 15949402A IL 159494 A0 IL159494 A0 IL 159494A0
Authority
IL
Israel
Prior art keywords
phosphonomethoxy
antiviral activity
pyrimidine derivatives
alkoxy pyrimidine
alkoxy
Prior art date
Application number
IL15949402A
Other languages
English (en)
Original Assignee
Acad Of Science Czech Republic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acad Of Science Czech Republic filed Critical Acad Of Science Czech Republic
Publication of IL159494A0 publication Critical patent/IL159494A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15949402A 2001-06-29 2002-06-28 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity IL159494A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30221201P 2001-06-29 2001-06-29
PCT/CZ2002/000038 WO2003002580A1 (en) 2001-06-29 2002-06-28 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity

Publications (1)

Publication Number Publication Date
IL159494A0 true IL159494A0 (en) 2004-06-01

Family

ID=23166777

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15949402A IL159494A0 (en) 2001-06-29 2002-06-28 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
IL159494A IL159494A (en) 2001-06-29 2003-12-22 Derivatives 6 – '2– (phosphonomethoxy) alkoxy pyrimidine with antiviral activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159494A IL159494A (en) 2001-06-29 2003-12-22 Derivatives 6 – '2– (phosphonomethoxy) alkoxy pyrimidine with antiviral activity

Country Status (21)

Country Link
US (2) US6818633B2 (xx)
EP (1) EP1406911B1 (xx)
JP (1) JP4545434B2 (xx)
KR (1) KR100891366B1 (xx)
CN (1) CN1329404C (xx)
AP (1) AP1622A (xx)
AU (1) AU2002315625B2 (xx)
BR (1) BRPI0210746B8 (xx)
CA (1) CA2452036C (xx)
CZ (1) CZ297267B6 (xx)
EA (1) EA006020B1 (xx)
ES (1) ES2564144T3 (xx)
HU (1) HU230519B1 (xx)
IL (2) IL159494A0 (xx)
MX (1) MXPA04000138A (xx)
NO (2) NO333788B1 (xx)
NZ (1) NZ530685A (xx)
PL (1) PL207187B1 (xx)
TR (1) TR200302288T2 (xx)
WO (1) WO2003002580A1 (xx)
ZA (1) ZA200400236B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2527805C (en) * 2003-06-16 2012-08-21 Institute Of Organic Chemistry And Biochemistry, Academy Of Sciences Of The Czech Republic Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
ES2401285T3 (es) 2004-12-16 2013-04-18 The Regents Of The University Of California Fármacos con el pulmón como diana
US20060211650A1 (en) * 2004-12-16 2006-09-21 Forest Laboratories, Inc. Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof
WO2007014352A2 (en) * 2005-07-27 2007-02-01 Gilead Sciences, Inc. Antiviral phosphonate conjugates for inhibition of hiv
US7473683B2 (en) 2005-09-14 2009-01-06 The Board Of Trustees Of The Leland Stanford Junior University Nonpolar thymidine analogs
WO2007047405A1 (en) * 2005-10-13 2007-04-26 Allergan, Inc. Ddc compositions
FR2908133B1 (fr) 2006-11-08 2012-12-14 Centre Nat Rech Scient Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
JP5847296B2 (ja) * 2011-05-10 2016-01-20 アラタナ セラピューティクス エン ヴェー ネコレトロウイルス感染症の治療に使用するための化合物
WO2014143643A1 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California, A California Corporation Acyclic nucleoside phosphonate diesters
CN104119385B (zh) * 2014-07-24 2017-04-05 廖国超 核苷类似物的磷酸酯前药及其应用
AU2015317972B2 (en) 2014-09-15 2019-10-17 The Regents Of The University Of California Nucleotide analogs
WO2017048956A1 (en) 2015-09-15 2017-03-23 The Regents Of The University Of California Nucleotide analogs
EP3784680A1 (en) * 2018-04-23 2021-03-03 Centre national de la recherche scientifique New antiviral acyclonucleoside analogues

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS233665B1 (en) 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CS263951B1 (en) 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS263952B1 (en) 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS264222B1 (en) 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
NZ222553A (en) 1986-11-18 1991-07-26 Bristol Myers Co Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions
CA2001715C (en) 1988-11-14 1999-12-28 Muzammil M. Mansuri Carbocyclic nucleosides and nucleotides
CA2297294C (en) * 1989-05-15 2005-11-08 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Phosphonomethoxymethylpurine/pyrimidine derivatives
MY104575A (en) 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5302585A (en) 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
SK280313B6 (sk) 1990-04-24 1999-11-08 �Stav Organick� Chemie A Biochemie Av �R N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov
US5356886A (en) 1990-07-19 1994-10-18 Beecham Group P.L.C. Antiviral phosphono-alken derivatives of purines
EP0468119A1 (en) 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Novel carbocyclic analogs of certain nucleosides
DK0481214T3 (da) 1990-09-14 1999-02-22 Acad Of Science Czech Republic Prolægemidler af phosphonater
US5208221A (en) 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
CZ284678B6 (cs) 1991-05-20 1999-01-13 Ústav Organické Chemie A Biochemie Avčr Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití
EP0531597A1 (en) * 1991-09-12 1993-03-17 Merrell Dow Pharmaceuticals Inc. Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
DE69218968T2 (de) 1991-10-11 1997-10-09 Inst Of Organic Chemistry And Antivirale acyclische phosphonomethoxyalkyl substituierte, alkenyl und alkynyl purin und pyrimidin-derivate
US6057305A (en) 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
EP0618214A1 (en) * 1993-04-01 1994-10-05 Merrell Dow Pharmaceuticals Inc. Unsaturated phosphonate derivatives of purines and pyrimidines
JP4086314B2 (ja) 1993-09-17 2008-05-14 ギリアード サイエンシーズ, インコーポレイテッド ヌクレオチドアナログ
US5977061A (en) 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use

Also Published As

Publication number Publication date
EA200400117A1 (ru) 2004-08-26
NO335725B1 (no) 2015-02-02
CN1533397A (zh) 2004-09-29
WO2003002580A1 (en) 2003-01-09
BR0210746A (pt) 2004-07-20
ZA200400236B (en) 2004-08-18
HUP0400345A2 (hu) 2004-09-28
BRPI0210746B1 (pt) 2018-09-18
US20030109499A1 (en) 2003-06-12
HUP0400345A3 (en) 2007-05-29
WO2003002580A8 (en) 2003-01-30
JP2005511490A (ja) 2005-04-28
CZ2004142A3 (cs) 2004-05-12
EP1406911B1 (en) 2016-01-06
NO333788B1 (no) 2013-09-16
CA2452036C (en) 2009-09-29
NO20035797L (no) 2004-02-24
PL207187B1 (pl) 2010-11-30
IL159494A (en) 2008-06-05
MXPA04000138A (es) 2005-06-06
PL366852A1 (en) 2005-02-07
US20050038058A1 (en) 2005-02-17
EP1406911A1 (en) 2004-04-14
JP4545434B2 (ja) 2010-09-15
ES2564144T3 (es) 2016-03-18
BRPI0210746B8 (pt) 2021-05-25
NZ530685A (en) 2006-09-29
TR200302288T2 (tr) 2004-12-21
AP1622A (en) 2006-06-16
CN1329404C (zh) 2007-08-01
BRPI0210746A8 (pt) 2018-07-10
CZ297267B6 (cs) 2006-10-11
NO20131091L (no) 2004-02-24
EA006020B1 (ru) 2005-08-25
US6818633B2 (en) 2004-11-16
CA2452036A1 (en) 2003-01-09
HU230519B1 (hu) 2016-10-28
KR100891366B1 (ko) 2009-04-02
AU2002315625B2 (en) 2008-05-01
AP2004002953A0 (en) 2004-03-31
KR20040027521A (ko) 2004-04-01

Similar Documents

Publication Publication Date Title
HUS2200038I1 (hu) HIV-gátló pirimidinszármazékok
IL159832A0 (en) 4-amino-6-phenyl-pyrrolo[2,3-d] pyrimidine derivatives
PL363866A1 (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
MXPA03006939A (es) Composicion y actividad antiviral de derivados de piperazina azaindoloxoacetica sustituidos.
HUP0402171A3 (en) Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
IL153754A0 (en) Pyrimidine derivatives
AU1041802A (en) Tetrahydro-heterocycloazepinyl pyrimidine derivatives
EP1458687A4 (en) pyrimidine
IL159494A0 (en) 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
HK1070071A1 (en) New pyrimidine compounds
EP1406619A4 (en) ANTIVIRAL AND ANTIMICROBIAL GUANIDINE OR BIGUANIDINE DERIVATIVES
AU2002362806A1 (en) Pyrimidine derivatives
HRP20030362A2 (en) Pyrimidine derivatives
GB0112802D0 (en) Pyrimidine derivatives
GB0112803D0 (en) Pyrimidine derivatives
AU2002352782A8 (en) Antitumor activity of bok
DE50103649D1 (de) 2-aminoalkyl-thieno[2,3-d]pyrimidine
EP1374911A4 (en) MEANS FOR MEASURING THE METABOLIZABILITY OF PYRIMIDINE
GB0119477D0 (en) Pyrimidine derivatives
GB0112809D0 (en) Pyrimidine derivatives
GB0112804D0 (en) Pyrimidine derivatives
GB0112808D0 (en) Pyrimidine derivatives
GB0112807D0 (en) Pyrimidine derivatives
GB0119475D0 (en) Pyrimidine derivatives
GB0112805D0 (en) Pyrimidine derivatives

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted